ARTICLE SUMMARY:
Next-generation mechanical thrombectomy devices will be the chief driver of growth in the neurovascular device market. New clinical data suggesting that interventional treatment even up to 24 hours after stroke onset is beneficial for some patients could almost triple the number of patients eligible for treatment. By Oded Ben-Joseph and Seth Bensussen, Outcome Capital
The global neurovascular device market was estimated at $1.62 billion in 2015 with projected growth to $2.92 billion by 2024 (see Figure 1).
